Abstract
Decreased susceptibility and resistance to first-line antibiotics have emerged in Neisseria gonorrhoeae worldwide, and resistance to broad-spectrum cephalosporins and azithromycin has raised special concerns. There have been many reports about high-level resistance to broad-spectrum cephalosporins and azithromycin in many regions, which raises alarms about combination therapy of gonorrhea. Mechanisms of drug resistance in Neisseria gonorrhoeae are extremely complex, mainly involving alterations in target sites of antibiotics, as well as decreased influx and increased efflux of antibiotics. These mechanisms depend on or synergize with each other to some extents. In-depth exploration into drug resistance in Neisseria gonorrhoeae may contribute to rational use of antibiotics in clinic and delay in the process of drug resistance. Key words: Neisseria gonorrhoeae; Gonorrhea; Cephalosporins; Drug resistance; Azithromycin
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Dermatology and Venereology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
